Suchergebnisse - "AIMM Trial Group:"

PubPharm (3)

1

Correction : Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

enthalten in: Trials | 2022

von AIMM Trial Group: | Abouhajar, A. | Alcock, L. | +23

ErratumFor: Trials. 2022 Sep 20;23(1):789. - PMID 36127727

2

Acipimox in Mitochondrial Myopathy (AIMM) : study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

enthalten in: Trials | 2022

von AIMM Trial Group: | Abouhajar, A. | Alcock, L. | +23

ErratumIn: Trials. 2022 Oct 5;23(1):852. - PMID 36199067

3

Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

in: Trials | 2022

von The AIMM Trial Group: | Alaa Abouhajar | Lisa Alcock | +23

1
[1]